Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119343) titled 'Efficacy and Safety of ATLG for Immunosuppressive Induction in Single-Center Marginal Deceased Donor Kidney Transplantation' on Feb. 25.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Kidney transplantation
Intervention:
Observation group (Patients undergoing kidney transplantation with immune induction using ATLG):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-25
Target Sample Size: Observation group (Patients undergoing kidney transplantation with immune induction using ATLG):50;Control group (...